So-Young International (NASDAQ:SY – Get Free Report) is set to release its earnings data before the market opens on Wednesday, November 20th. So-Young International has set its Q3 2024 guidance at EPS.Investors interested in participating in the company’s conference call can do so using this link.
So-Young International (NASDAQ:SY – Get Free Report) last announced its quarterly earnings results on Friday, August 23rd. The company reported $0.02 EPS for the quarter. The company had revenue of $56.06 million for the quarter. So-Young International had a net margin of 2.23% and a return on equity of 1.32%.
So-Young International Trading Up 0.9 %
Shares of NASDAQ:SY opened at $0.89 on Monday. The firm has a 50 day simple moving average of $0.92 and a 200-day simple moving average of $0.99. So-Young International has a twelve month low of $0.66 and a twelve month high of $1.52. The company has a market capitalization of $91.69 million, a PE ratio of 22.21 and a beta of 0.91.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Report on So-Young International
About So-Young International
So-Young International Inc operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users medical aesthetic knowledge and experience to reach an informed medical aesthetic treatment decision and make reservations for treatment with medical professionals and medical aesthetic institutions; So-Young Beauty which provides similar interfaces and functions as the mobile app, as well as serves as additional access points to the platform; and medical aesthetic community content through its website soyoung.com.
Featured Stories
- Five stocks we like better than So-Young International
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Comparing and Trading High PE Ratio Stocks
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for So-Young International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for So-Young International and related companies with MarketBeat.com's FREE daily email newsletter.